AUS
NZ
UK
CA
USA
IND
Healthcare
Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Delay
December 03, 2020 09:18 AM GMT| By Hina ChowdharySummary In a first, the UK has swiftly approved the Pfizer-BioNTech developed coronavirus vaccine The drug regulators across various nations including the US and the EU’s basket of countries are working on expediting the approval process .....
MHRA approves Pfizer-BioNTech vaccine for the UK, will be available from next week
December 02, 2020 08:21 AM GMT| By Kunal SawhneyIn a historic development, the Medicines and Healthcare Products Regulatory Authority (MHRA) of the United Kingdom has given approval to the Pfizer-BioNTech vaccine. With this, the UK has become the first western country ahead of the US and Europe to...
UK First Nation To Approve Pfizer-BioNTech COVID-19 Vaccine, Roll Out ‘Next Week'
December 02, 2020 07:53 AM GMT| By Team Kalkine MediaIn a major development, the United Kingdom on Wednesday became the first nation to approve the Pfizer-BioNTech vaccination for public use. The COVID-19 mRNA vaccine candidate will be rolled out from next week, informed UK health secretary Matt Hancoc...
AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related medicines in Europe
December 01, 2020 04:20 PM GMT| By Kunal SawhneyAstraZeneca PLC (LON: AZN) will be selling its rights of Crestor and some related medicines to Germany-based Grünenthal GmbH in more than 30 countries of Europe except the UK and Spain. The deal is worth up to $350 million. AstraZeneca will con...
Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday
November 28, 2020 10:50 AM GMT| By Hina ChowdharyShares of Indivior, the Chesterfield-headquartered pharmaceuticals company, crashed nearly 20 per cent at the close of the trading window on Friday, 28 November after the Slough-based healthcare-to-consumer goods manufacturer Reckitt Benckiser Group...
Oxford Covid-19 vaccine faces questions after dosing error
November 27, 2020 09:11 AM GMT| By Kunal SawhneyThough the recent back-to-back advancements in the development of a vaccine seemed to have enhanced the visibility of a silver lining in the fight against Covid-19 (SARS-CoV-2) virus, the hope of getting a clinically-approved vaccine remains bleak un...
Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceuticals (NASDAQ: ICPT), Teva Pharmaceutical (NYSE: TEVA)
November 24, 2020 09:04 AM GMT| By Kunal SawhneyThe pharmaceuticals industry has also been gripped by the aftereffects of coronavirus pandemic as even the pharma shares representing some of the major corporations like Novartis AG (NYSE: NVS), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) have been...
COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency in Late-Stage Trials
November 23, 2020 02:41 PM GMT| By Hina ChowdharySummary AstraZeneca said the Covid-19 vaccination, which the firm has been developing along with Oxford University, has shown a 70 per cent efficacy AstraZeneca CEO Pascal Soriot said the results are positive and show that it is highly effectiv.....
Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approval
November 21, 2020 12:44 PM GMT| By Kunal SawhneyPfizer and its partner BioNTech have submitted their report seeking early approvals from FDA for its Covid-19 vaccine The company has also started with its submissions in other countries such as Australia, Canada, Europe, Japan and the UK...
Pfizer-BioNTech vaccine to face stiff competition despite high success rate in trials
November 12, 2020 04:37 PM GMT| By Kunal SawhneySummary The vaccine candidate was found to be 90 per cent efficient in preventing Covid-19 infection, making it one of the most effective against the virus. The vaccine, however, is not going to be available for at least a few months before the.....
Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results
November 10, 2020 09:23 AM GMT| By Hina ChowdharyStock markets across the world witnessed a sharp uptick on Monday after initial data of a clinical trial showed that Pfizer and BioNTech’s vaccine candidate was more than 90 per cent effective in preventing COVID-19. Shares of both the pharm.....
GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments
November 10, 2020 04:33 AM GMT| By Hina ChowdharyGE Healthcare is the healthcare division of the American multinational conglomerate, General Electric (NYSE: GE). The division alone is valued at US$16.7 billion and provides medical technology and related digital solutions on a global scale. .....
Arix Bioscience plc’s VelosBio to be acquired by Merck
November 06, 2020 01:36 PM GMT| By Team Kalkine MediaSummary NYSE listed Merck acquired VelosBio, a portfolio company of Arix Bioscience for US$2.75 billion Arix’s investment in VelosBio grew by 12 times Merck acquired VelosBio to bolster its oncology pipeline The global venture capit.....
TFF Pharmaceuticals releases results for Q3 2020
November 06, 2020 11:15 AM GMT| By Kunal SawhneySummary TFF Pharmaceuticals Inc. was incorporated in 2018 as a clinical-stage biopharmaceutical company The company’s patented technology platform, Thin Film Freezing, or TFF helps it in developing and commercializing innovative drug prod.....
How are these two AIM stocks performing: LiDCO Group Plc and TomCo Energy Plc?
November 03, 2020 02:27 PM GMT| By Kunal SawhneySummary LiDCO Group Plc witnessed sales growth of 75% year-on-year during H1 FY21. The Company is getting acquired by Masimo Corporation. TomCo Energy Plc's POSP is expected to be operational by November 2020. The estimated capital cost for a.....
AstraZeneca’s Potential Covid-19 Vaccine Goes Under Accelerated Review
November 02, 2020 05:07 PM GMT| By Kunal SawhneySummary The UK’s Medicines and Healthcare Products Regulatory Agency has started the rolling review of AstraZeneca’s potential Covid- 19 vaccine, paving the way for its early roll-out The company had given an earlier roll-out schedu.....
Performance Review of Two Stocks Trending on the LSE: GlaxoSmithKline Plc & Ibstock Plc
October 29, 2020 03:49 PM GMT| By Kunal SawhneySummary GlaxoSmithKline Plc reported a revenue decline of 8% for Q3 FY20 The Company partnered with COVAX to provide 200 million doses of Covid-19 vaccine. Ibstock Plc has reported a revenue of 88% of last year in Q3 FY20. The Company expects.....
Boots UK To Offer 12-Minute Covid-19 Test Service
October 27, 2020 03:29 PM GMT| By Kunal SawhneySummary Boots will roll out new LumiraDx devices with the help of which the swab test Covid-19 results can be processed in just 12 minutes Boots will be launching a designated pre-flight Covid-19 testing service with the results of the test typ.....
Covid-19: Astrazeneca and Johnson & Johnson To Resume Vaccine Trials In the US
October 26, 2020 08:00 AM GMT| By Team Kalkine MediaSummary Drugmakers AstraZeneca and Johnson & Johnson will resume their clinical trials in the US from this week The Food and Drug Administration on Friday authorised AstraZeneca to restart their trial in the US Johnson & Johnson said t.....
Pfizer’s Covid-19 vaccine might spark Christmas spirits in the UK
October 19, 2020 05:43 PM BST| By Team Kalkine MediaSummary Pfizer said that after receiving the necessary approvals, stacks of its Covid-19 vaccine would be ready for dispatch from its production unit. An emergency approval for Pfizer’s vaccine would be sought in the US in November 2020 .....
